Best Stocks
Large pharmaceutical firms are currently seeking to acquire de-risked assets to compensate for significant revenue losses caused by expiring patents. The analysis highlights Crinetics Pharmaceuticals and Cytokinetics as the top candidates for acquisition. Full report: https://www.procapinsights.com/ ProCap Insights is a research division of ProCap Financial. This podcast is for informational and analytical purposes only. It does not constitute individualized financial, investment, tax, legal, accounting, or other professional advice. You should consult with qualified professionals before making significant financial decisions. You are solely responsible for any decisions you make using or based on information provided herein. Nothing in this podcast should be construed as a solicitation or recommendation to buy or sell any financial instrument.
70 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de Best Stocks community!